KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Operating Income: 2010-2015

Historic Operating Income for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to -$13.2 million.

  • Biocryst Pharmaceuticals' Operating Income fell 13.37% to -$13.2 million in Q3 2015 from the same period last year, while for Sep 2015 it was -$37.4 million, marking a year-over-year decrease of 1.24%. This contributed to the annual value of -$45.8 million for FY2014, which is 49.01% down from last year.
  • According to the latest figures from Q3 2015, Biocryst Pharmaceuticals' Operating Income is -$13.2 million, which was down 346.39% from $5.3 million recorded in Q2 2015.
  • Biocryst Pharmaceuticals' Operating Income's 5-year high stood at $5.3 million during Q2 2015, with a 5-year trough of -$15.2 million in Q4 2014.
  • For the 3-year period, Biocryst Pharmaceuticals' Operating Income averaged around -$9.0 million, with its median value being -$11.6 million (2014).
  • Per our database at Business Quant, Biocryst Pharmaceuticals' Operating Income slumped by 139.28% in 2014 and then surged by 145.98% in 2015.
  • Over the past 5 years, Biocryst Pharmaceuticals' Operating Income (Quarterly) stood at -$11.0 million in 2011, then rose by 11.51% to -$10.2 million in 2012, then declined by 19.32% to -$6.3 million in 2013, then slumped by 139.28% to -$15.2 million in 2014, then decreased by 13.37% to -$13.2 million in 2015.
  • Its last three reported values are -$13.2 million in Q3 2015, $5.3 million for Q2 2015, and -$14.4 million during Q1 2015.